Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

Androgen deprivation therapy (ADT) is the standard care for prostate cancer (PCa) patients who fail surgery or radiotherapy. While initially effective, the cancer almost always recurs as a more aggressive castration resistant prostate cancer (CRPC). Previous studies have demonstrated that chromatin...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Saraç, H, Morova, T, Pires, E, McCullagh, J, Kaplan, A, Cingöz, A, Bagci-Onder, T, Önder, T, Kawamura, A, Lack, NA
פורמט: Journal article
שפה:English
יצא לאור: Springer Nature 2019

פריטים דומים

פריטים דומים